Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Re-TREAT: A Phase 2 Study of Stereotactic Re-irradiation of Relapsed Brain Metastases

NCT05126875 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05126875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05126875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Re-TREAT: A Phase 2 Study of Stereotactic Re-irradiation of Relapsed Brain Metastases
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2021
Completion date
August 20, 2023
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult, cancer